• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尤因肉瘤潜在关键生物标志物的筛选:来自基因阵列分析的证据

Screening of Potential Key Biomarkers for Ewing Sarcoma: Evidence from Gene Array Analysis.

作者信息

Zhong Duming, Chen Dan, Zhang Guangquan, Lin Shaobai, Mei Runhong, Yu Xuefeng

机构信息

Department of Orthopedics, The Fourth Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China.

出版信息

Int J Gen Med. 2022 Mar 5;15:2575-2588. doi: 10.2147/IJGM.S346251. eCollection 2022.

DOI:10.2147/IJGM.S346251
PMID:35342299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8943648/
Abstract

BACKGROUND

Ewing's sarcoma (ES) is a common bone cancer in children and adolescents. There are ethnic differences in the incidence and treatment effects. People have made great efforts to clarify the cause; however, the molecular mechanism of ES is still poorly understood.

METHODS

We download the microarray datasets GSE68776, GSE45544 and GSE17674 from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) of the three datasets were screened and enrichment analysis was performed. STRING and Cytoscape were used to carry out module analysis, building a protein-protein interaction (PPI) network. Finally, a series of analyses such as survival analysis and immune infiltration analysis were performed on the selected genes.

RESULTS

A total of 629 differentially expressed genes were screened, including 206 up-regulated genes and 423 down-regulated genes. The pathways and rich-functions of DEGs include protein activation cascade, carbohydrate binding, cell-cell adhesion junctions, mitotic cell cycle, p53 pathway, and cancer pathways. Then, a total of 10 hub genes were screened out. Biological process analysis showed that these genes were mainly enriched in mitotic nuclear division, protein kinase activity, cell division, cell cycle, and protein phosphorylation.

CONCLUSION

Survival analysis and multiple gene comparison analysis showed that CDCA8, MAD2L1 and FANCI may be involved in the occurrence and prognosis of ES. The purpose of our study is to clarify the DEG and key genes, which will help us know more about the molecular mechanisms of ES, provide potential pathway or targets for the diagnosis and treatment.

摘要

背景

尤因肉瘤(ES)是儿童和青少年常见的骨癌。其发病率和治疗效果存在种族差异。人们已付出巨大努力来阐明病因;然而,ES的分子机制仍知之甚少。

方法

我们从基因表达综合数据库(GEO)下载了微阵列数据集GSE68776、GSE45544和GSE17674。筛选这三个数据集的差异表达基因(DEGs)并进行富集分析。使用STRING和Cytoscape进行模块分析,构建蛋白质 - 蛋白质相互作用(PPI)网络。最后,对所选基因进行生存分析和免疫浸润分析等一系列分析。

结果

共筛选出629个差异表达基因,其中上调基因206个,下调基因423个。DEGs的通路和富集功能包括蛋白质激活级联反应、碳水化合物结合、细胞间粘附连接、有丝分裂细胞周期、p53通路和癌症通路。然后,共筛选出10个枢纽基因。生物学过程分析表明,这些基因主要富集在有丝分裂核分裂、蛋白激酶活性、细胞分裂、细胞周期和蛋白质磷酸化。

结论

生存分析和多基因比较分析表明,CDCA8、MAD2L1和FANCI可能参与ES的发生和预后。我们研究的目的是阐明DEG和关键基因,这将有助于我们更多地了解ES的分子机制,为诊断和治疗提供潜在途径或靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/4db39a96630f/IJGM-15-2575-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/9fbd8d59f74a/IJGM-15-2575-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/cec86ab4ad1e/IJGM-15-2575-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/2caa5ff4dc43/IJGM-15-2575-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/5734c32d3f91/IJGM-15-2575-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/9950fbc1eafc/IJGM-15-2575-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/21d2c1a908d1/IJGM-15-2575-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/c4bb17828fd3/IJGM-15-2575-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/4db39a96630f/IJGM-15-2575-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/9fbd8d59f74a/IJGM-15-2575-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/cec86ab4ad1e/IJGM-15-2575-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/2caa5ff4dc43/IJGM-15-2575-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/5734c32d3f91/IJGM-15-2575-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/9950fbc1eafc/IJGM-15-2575-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/21d2c1a908d1/IJGM-15-2575-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/c4bb17828fd3/IJGM-15-2575-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d68/8943648/4db39a96630f/IJGM-15-2575-g0008.jpg

相似文献

1
Screening of Potential Key Biomarkers for Ewing Sarcoma: Evidence from Gene Array Analysis.尤因肉瘤潜在关键生物标志物的筛选:来自基因阵列分析的证据
Int J Gen Med. 2022 Mar 5;15:2575-2588. doi: 10.2147/IJGM.S346251. eCollection 2022.
2
Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma.慢肌肌钙蛋白T、肌联蛋白和肌球蛋白轻链3是尤因肉瘤潜在的预后生物标志物。
Oncol Lett. 2019 Dec;18(6):6431-6442. doi: 10.3892/ol.2019.11044. Epub 2019 Nov 4.
3
Identification and validation of a novel ubiquitination-related gene in Ewing's sarcoma.尤因肉瘤中一个新的泛素化相关基因的鉴定与验证
Front Oncol. 2023 Feb 16;13:1000949. doi: 10.3389/fonc.2023.1000949. eCollection 2023.
4
Identification of key genes and pathways in Ewing's sarcoma using bioinformatics analysis.利用生物信息学分析鉴定尤因肉瘤中的关键基因和信号通路。
J BUON. 2018 Sep-Oct;23(5):1472-1480.
5
Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways.尤因肉瘤的生物信息学分析:寻找关键候选基因和通路。
Oncol Lett. 2019 Dec;18(6):6008-6016. doi: 10.3892/ol.2019.10936. Epub 2019 Sep 30.
6
Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing's sarcoma.下调的膜联蛋白 A1 表达与尤因肉瘤的不良预后、转移和免疫抑制微环境相关。
Aging (Albany NY). 2023 Mar 28;15(6):2321-2346. doi: 10.18632/aging.204615.
7
Identification of driver genes associated with chemotherapy resistance of Ewing's sarcoma.与尤因肉瘤化疗耐药相关的驱动基因的鉴定
Onco Targets Ther. 2018 Oct 15;11:6947-6956. doi: 10.2147/OTT.S172190. eCollection 2018.
8
Identification of key genes and pathways in Ewing's sarcoma patients associated with metastasis and poor prognosis.尤因肉瘤患者中与转移和预后不良相关的关键基因和通路的鉴定。
Onco Targets Ther. 2019 May 27;12:4153-4165. doi: 10.2147/OTT.S195675. eCollection 2019.
9
Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.通过生物信息学分析鉴定与 SCLC 相关的候选生物标志物和途径。
Mol Med Rep. 2018 Aug;18(2):1538-1550. doi: 10.3892/mmr.2018.9095. Epub 2018 May 29.
10
Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.基于生物信息学分析的肝细胞癌关键生物标志物的筛选和鉴定。
Oncol Rep. 2017 Nov;38(5):2607-2618. doi: 10.3892/or.2017.5946. Epub 2017 Sep 7.

本文引用的文献

1
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer.全球磷酸蛋白质组学揭示 CDK 抑制是胰腺癌细胞对 KRas 成瘾的一个弱点。
Clin Cancer Res. 2021 Jul 15;27(14):4012-4024. doi: 10.1158/1078-0432.CCR-20-4781. Epub 2021 Apr 20.
2
CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.环状 RNA 甲基转移酶样 3 (METTL3)在 m6A 依赖性方式上调,促进乳腺癌进展。
Int J Biol Sci. 2021 Mar 15;17(5):1178-1190. doi: 10.7150/ijbs.57783. eCollection 2021.
3
Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression.
MAPK/ERK 信号通路与 MicroRNAs 的相互作用:调控癌细胞代谢和肿瘤进展的关键机制。
Life Sci. 2021 Aug 1;278:119499. doi: 10.1016/j.lfs.2021.119499. Epub 2021 Apr 15.
4
Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β-Catenin Signaling.沉默CDCA8通过恢复ATF3肿瘤抑制因子和使AKT/β-连环蛋白信号失活来抑制肝细胞癌的生长和干性。
Cancers (Basel). 2021 Mar 2;13(5):1055. doi: 10.3390/cancers13051055.
5
Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy.Polo样激酶4在癌症发展中的关键作用及针对Plk4的治疗策略。
Front Oncol. 2021 Mar 12;11:587554. doi: 10.3389/fonc.2021.587554. eCollection 2021.
6
Woman with Turner syndrome and her child with acute leukemia (a case report).特纳综合征女性及其罹患急性白血病的孩子(病例报告)。
Exp Oncol. 2020 Dec;42(4):333-336. doi: 10.32471/exp-oncology.2312-8852.vol-42-no-4.15275.
7
Identification of NCAPH as a biomarker for prognosis of breast cancer.鉴定 NCAPH 作为乳腺癌预后的生物标志物。
Mol Biol Rep. 2020 Oct;47(10):7831-7842. doi: 10.1007/s11033-020-05859-9. Epub 2020 Oct 3.
8
NCAPH is negatively associated with Mcl‑1 in non‑small cell lung cancer.NCAPH 与非小细胞肺癌中的 Mcl‑1 呈负相关。
Mol Med Rep. 2020 Oct;22(4):2916-2924. doi: 10.3892/mmr.2020.11359. Epub 2020 Jul 28.
9
Visualizing and interpreting cancer genomics data via the Xena platform.通过Xena平台可视化和解读癌症基因组学数据。
Nat Biotechnol. 2020 Jun;38(6):675-678. doi: 10.1038/s41587-020-0546-8.
10
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.